Cargando…
Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis
Glucocorticosteroids (GCs) have been employed extensively for the treatment of rheumatoid arthritis (RA) and other autoimmune and systemic inflammatory disorders. Their use is supported by extensive literature and their utility is reflected in their incorporation into current treatment guidelines fo...
Autores principales: | Kavanaugh, Arthur, Wells, Alvin F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165844/ https://www.ncbi.nlm.nih.gov/pubmed/24729402 http://dx.doi.org/10.1093/rheumatology/keu135 |
Ejemplares similares
-
Glucocorticoid management in rheumatoid arthritis: morning or night low dose?
por: Paolino, Sabrina, et al.
Publicado: (2017) -
The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis
por: Cutolo, Maurizio, et al.
Publicado: (2014) -
Interleukin-6 inhibitors in the treatment of rheumatoid arthritis
por: Hennigan, Stephanie, et al.
Publicado: (2008) -
Long-term treatment with low dose glucocorticoids in Rheumatoid Arthritis: New tricks of an old drug
por: Nikas, Spyros N.
Publicado: (2018) -
A critical evaluation of the role of subcutaneous abatacept in the treatment of rheumatoid arthritis: patient considerations
por: Wells, Alvin F, et al.
Publicado: (2014)